BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1719950)

  • 1. [The use of monoclonal antibodies to cytokeratin peptides for the diagnosis of basal cell carcinoma of the skin].
    Petrov SV; Raĭkhlin NT; Serre G
    Arkh Patol; 1991; 53(6):7-11. PubMed ID: 1719950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma.
    Habets JM; Tank B; Vuzevski VD; Brevé J; Stolz E; van Joost T
    Anticancer Res; 1988; 8(4):611-6. PubMed ID: 2460019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns of keratin protein expression in basal cell, metatypical and squamous cell carcinoma of human skin].
    Karelina TV; Kazantseva IA
    Arkh Patol; 1991; 53(4):29-32. PubMed ID: 1714712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytokeratin 8 and low molecular weight cytokeratins in human basal cell carcinoma.
    Kooy AJ; Tank B; Vuzevski VD; Van Joost T
    Anticancer Res; 1995; 15(2):241-7. PubMed ID: 7539235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin expression in trichilemmal carcinoma suggests differentiation towards follicular infundibulum.
    Kurokawa I; Senba Y; Nishimura K; Habe K; Hakamada A; Isoda K; Yamanaka K; Mizutani H; Tsubura A
    In Vivo; 2006; 20(5):583-5. PubMed ID: 17091763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytokeratin profile of canine epithelial skin tumours.
    Walter J
    J Comp Pathol; 2000 May; 122(4):278-87. PubMed ID: 10805981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S; Arase S; Kawana S; Kimura T
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoelectron microscopic studies on cytokeratins in human basal cell carcinoma.
    Habets JM; Tank B; Vuzevski VD; Brevé J; Van der Kwast T; Van Joost T
    Anticancer Res; 1989; 9(1):65-70. PubMed ID: 2468307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokeratins--survey of incidence in normal and diseased skin. II. Cytokeratin expression in diseased skin].
    Heidenbluth I; Conrad K
    Dermatol Monatsschr; 1990; 176(2-3):87-95. PubMed ID: 1694796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laminin and heparan sulfate proteoglycan of the basal membrane in basal cell cancer (an immunohistochemical study using monoclonal antibodies)].
    Petrov SV; Raĭkhlin AN
    Vopr Onkol; 1991; 37(5):550-3. PubMed ID: 1767508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphology, diagnosis, differential diagnosis, and early diagnosis of malignant and potentially malignant skin neoplasms. I. Basalioma, carcinoma, sarcoma of the skin].
    Jung HD
    Dtsch Gesundheitsw; 1972 Jan; 27(3):123-8. PubMed ID: 4336637
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: "Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma", in J Cutan Pathol 2009; 36: 543.
    Chen JT; Hsu JD; Yao CC; Han LW; Han CP
    J Cutan Pathol; 2010 Oct; 37(10):1123-4. PubMed ID: 20175827
    [No Abstract]   [Full Text] [Related]  

  • 13. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study.
    Kooy AJ; Tank B; de Jong TA; Vuzevski VD; Bosman FT; van Joost T
    Anticancer Res; 1996; 16(1):277-82. PubMed ID: 8615621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescent localization of cytokeratin intermediate filaments as a means of defining the presence of recurrent basal cell carcinoma.
    Ronnen M; Suster S; Orenstein A
    Cutis; 1988 Oct; 42(4):359-62. PubMed ID: 2466615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
    Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
    BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis of basalioma and metatypical skin cancer].
    Kazantseva IA; Bogatyreva II; Vavilov AM; Parshikova SM
    Arkh Patol; 1983; 45(6):35-9. PubMed ID: 6625927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basalioma].
    Diem E
    Ther Umsch; 1993 Dec; 50(12):812-6. PubMed ID: 8171402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An immunohistochemical study on basal cell epithelioma using anti-keratin monoclonal antibodies].
    Shimizu N
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):691-7. PubMed ID: 2442439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.